| Balance Sheets | 2025-09-30 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 217,442 | |||
| Marketable securities | 1,714,066 | |||
| Prepaid expenses and other current assets | 45,981 | |||
| Total current assets | 1,977,489 | |||
| Property and equipment, gross | 59,940 | |||
| Less accumulated depreciation and amortization | 27,014 | |||
| Property and equipment, net | 32,926 | |||
| Operating lease right-of-use asset | 134,450 | |||
| Intangible assets, net | 55,869 | |||
| Goodwill | 14,608 | |||
| Restricted cash | 4,858 | |||
| Long-term deposits | 16,851 | |||
| Other noncurrent assets | 14,869 | |||
| Total assets | 2,251,920 | |||
| Accounts payable | 74,849 | |||
| Accrued expenses and other current liabilities | 154,447 | |||
| Operating lease liability, current | 16,326 | |||
| Total current liabilities | 245,622 | |||
| Deferred tax liability | 2,353 | |||
| Operating lease liability, noncurrent | 142,135 | |||
| Liability related to the sale of future royalties | 256,509 | |||
| Warrant liability | 5,918 | |||
| Other noncurrent liabilities | 2,479 | |||
| Total liabilities | 655,016 | |||
| Common stock, 0.0001 par value 300,000,000 shares authorized as of september 30, 2025 and december 31, 2024, respectively 189,710,951 and 185,896,625 shares issued and outstanding as of september 30, 2025 and december 31, 2024, respectively | 18 | |||
| Additional paid-in capital | 4,097,980 | |||
| Accumulated other comprehensive income | 3,116 | |||
| Accumulated deficit | -2,504,210 | |||
| Total stockholders' equity | 1,596,904 | |||
| Total liabilities and stockholders' equity | 2,251,920 | |||
Revolution Medicines, Inc. (RVMDW)
Revolution Medicines, Inc. (RVMDW)